Englewood Lab, Inc. (KOSDAQ:950140)
11,290
-230 (-2.00%)
At close: Apr 9, 2026
Englewood Lab Revenue
In the year 2025, Englewood Lab had annual revenue of 216.79B KRW with 18.97% growth. Englewood Lab had revenue of 54.52B in the quarter ending December 31, 2025, with 28.73% growth.
Revenue
216.79B
Revenue Growth
+18.97%
P/S Ratio
1.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
225.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 216.79B | 34.57B | 18.97% |
| Dec 31, 2024 | 182.22B | -24.56B | -11.88% |
| Dec 31, 2023 | 206.78B | 55.28B | 36.48% |
| Dec 31, 2022 | 151.51B | -9.31B | -5.79% |
| Dec 31, 2021 | 160.82B | 23.65B | 17.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmecca Korea | 640.93B |
| CLIO Cosmetics Co.,Ltd | 328.90B |
| C&C International | 288.48B |
| Manyo Factory | 113.02B |
| Icure Pharmaceutical Incorporation | 83.38B |
| Genic | 78.20B |
| Coreana Cosmetics | 73.68B |
| Nowcos | 35.64B |